Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome
Key facts
- Who runs it
- Center of New Medical Technologies
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Apr 2026
- Expected to end
- 1 Jul 2028
- Type of study
- Observational, 2 groups
- Record updated
- 30 March 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Verified MS per NCEP-ATP III criteria
- Ability to undergo all procedures (fasting blood draw, breath test, stool antigen, endoscopy/biopsy, anthropometry)
Who cannot take part
- Current metabolic-influencing therapy
- Planned surgery/long hospitalization
- Gastric resection or upper GI reconstruction
- Acute/chronic infection or autoimmune flare
- Active malignancies
- Severe liver/kidney failure
- Type 1 diabetes
- Interventional study participation in last 3 months
- Pregnancy/lactation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial is currently available in Russia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.
The 2 groups in the trial
- group with persistence of H. pylori
group with metabolic syndrome and persistence of H. pylori
- group without persistence of H. pylori
group without metabolic syndrome and persistence of H. pylori
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome Cohort Observational Study
- Criteria questions
- Built from NCT07501858, who can take part
- Record updated
- 30 March 2026